WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Inovio Pharmaceuticals revenue was $217.76k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $117.0k, up Infinity% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INO annual revenue was $217.8k, with -73.8% growth year-over-year.

INO past revenue growth

How has INO's revenue growth performed historically?

Company
-73.83%
Industry
497.69%
Market
20.68%
INO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INO revenue history

Current Revenue
$217.8k
Current Earnings
-$107.3M
Current Profit Margin
-49,254.3%

Be the first to know when INO announces revenue.

INO Revenue History By Year

INO Yearly RevenueINO RevenueINO ChangeINO Revenue Growth
2024-12-31$217.76k-$614.25k-73.83%
2023-12-31$832.01k-$9.43M-91.89%
2022-12-31$10.26M$8.49M+478.23%
2021-12-31$1.77M-$5.64M-76.05%
2020-12-31$7.41M$3.30M+80.24%
2019-12-31$4.11M-$26.37M-86.51%
2018-12-31$30.48M-$11.74M-27.80%
2017-12-31$42.22M$6.85M+19.37%
2016-12-31$35.37M-$5.20M-12.83%
2015-12-31$40.57M$30.12M+288.00%
2014-12-31$10.46M-$3.01M-22.35%
2013-12-31$13.47M$9.35M+226.98%
2012-12-31$4.12M-$5.68M-57.95%
2011-12-31$9.80M$3.65M+59.41%
2010-12-31$6.14M-$2.98M-32.62%
2009-12-31$9.12M$7.02M+334.78%
2008-12-31$2.10M-$2.71M-56.37%
2007-12-31$4.81M$1.34M+38.62%
2006-12-31$3.47M-$2.00M-36.56%
2005-12-31$5.47M$4.30M+368.45%
2004-12-31$1.17M$1.09M+1,349.29%
2003-12-31$80.53k-$108.99k-57.51%
2002-12-31$189.52k-$4.10M-95.58%
2001-03-31$4.29M-$786.15k-15.48%
2000-03-31$5.08M-$3.24M-38.98%
1999-03-31$8.32M$4.66M+127.43%
1998-03-31$3.66M$499.41k+15.81%
1997-02-28$3.16MN/AN/A

1 of 2

Inovio Pharmaceuticals Revenue FAQ

What was INO's revenue last quarter?

On Invalid Date, Inovio Pharmaceuticals (NASDAQ: INO) reported Q4 2024 revenue of $116.99 thousand up 13.97% year over year. In the same quarter last year, Inovio Pharmaceuticals's revenue was $102.65 thousand.

What was Inovio Pharmaceuticals's revenue in 2024?

Inovio Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $217.76 thousand, a 73.83% decrease year over year.

How much does Inovio Pharmaceuticals make in a day?

Based on Inovio Pharmaceuticals annual revenue for the past five years, INO makes an average of $11,231.79 per day.

What was Inovio Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Inovio Pharmaceuticals's revenue has grown -73.83% year over year. This is 571.52 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Inovio Pharmaceuticals's revenue in the past year totaled $217.76 thousand.

How much does Inovio Pharmaceuticals make in a year?

Inovio Pharmaceuticals's revenue by year for the past five years is:
  • Inovio Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $217.76 thousand, a 73.83% decrease year over year.
  • Inovio Pharmaceuticals's annual revenue for Dec 31, 2023 was $832.01 thousand, a 91.89% decrease from 2022.
  • Inovio Pharmaceuticals's annual revenue for 2022 was $10.26 million, a 478.23% increase from 2021.
  • Inovio Pharmaceuticals's annual revenue for 2021 was $1.77 million, a 76.05% decrease from 2020.
  • Inovio Pharmaceuticals's annual revenue for 2020 was $7.41 million, a 80.24% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.